Xiangjun Zeng

5PUBLICATIONS
10CO-AUTHORS
Regenerative medicine (incl. stem cells)Tissue engineeringRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 08, 2025
A Soluble Receptor for Advanced Glycation End-Products Attenuates Myocardial Ischemia/Reperfusion Injury via Enhancing Glucose Metabolism.

Haosheng Wu, Jie Zhang, Xue Jiang

|Jun 19, 2025
Apelin Alleviated Endothelial-To-Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy.

Chunmeng Fan, Yu Liu, Jing Chang

|Jan 15, 2025
Apelin-13 inhibits ischemia-reperfusion mediated podocyte apoptosis by reducing m-TOR phosphorylation to enhance autophagy.

Xiang Zheng, Dongshan Chen, Jiyue Wu

|Dec 16, 2021
Protective Effects of the Soluble Receptor for Advanced Glycation End-Products on Pyroptosis during Myocardial Ischemia-Reperfusion.

Yingming Liu, Xinying Guo, Jie Zhang

|Jan 28, 2021
Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction.

Bin Li, Jiming Yin, Jing Chang

Pageof 1

Frequent Collaborators

2 joint publications

Xiang Zheng

2 joint publications

Mingcong Huang

2 joint publications

Chunmeng Fan

1 joint publications

Caixia Guo